115 related articles for article (PubMed ID: 24790001)
1. Effect of dietary fiber on the level of free angiotensin II receptor blocker in vitro.
Iwazaki A; Takahashi K; Tamezane Y; Tanaka K; Nakagawa M; Imai K; Nakanishi K
Biol Pharm Bull; 2014; 37(5):779-84. PubMed ID: 24790001
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
Le MT; Pugsley MK; Vauquelin G; Van Liefde I
Br J Pharmacol; 2007 Aug; 151(7):952-62. PubMed ID: 17572702
[TBL] [Abstract][Full Text] [Related]
3. Do all angiotensin II type 1 receptor blockers have the same beneficial effects?
Miura S; Saku K
Br J Pharmacol; 2007 Aug; 151(7):912-3. PubMed ID: 17572701
[TBL] [Abstract][Full Text] [Related]
4. Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling.
Bhuiyan MA; Ishiguro M; Hossain M; Nakamura T; Ozaki M; Miura S; Nagatomo T
Life Sci; 2009 Jul; 85(3-4):136-40. PubMed ID: 19446572
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
Kakuta H; Sudoh K; Sasamata M; Yamagishi S
Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
[TBL] [Abstract][Full Text] [Related]
7. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation.
Yamagishi S; Takenaka K; Inoue H
Med Hypotheses; 2006; 66(1):118-20. PubMed ID: 16154710
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan: a different angiotensin II receptor blocker protecting a different population?
Burnier M
J Int Med Res; 2009; 37(6):1662-79. PubMed ID: 20146864
[TBL] [Abstract][Full Text] [Related]
9. Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Weiss J; Sauer A; Divac N; Herzog M; Schwedhelm E; Böger RH; Haefeli WE; Benndorf RA
Biopharm Drug Dispos; 2010 Mar; 31(2-3):150-61. PubMed ID: 20222053
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary fibers on losartan uptake and transport in Caco-2 cells.
Iwazaki A; Takahashi N; Miyake R; Hiroshima Y; Abe M; Yasui A; Imai K
Biopharm Drug Dispos; 2016 May; 37(4):212-9. PubMed ID: 26748460
[TBL] [Abstract][Full Text] [Related]
11. Unique "delta lock" structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor.
Ohno K; Amano Y; Kakuta H; Niimi T; Takakura S; Orita M; Miyata K; Sakashita H; Takeuchi M; Komuro I; Higaki J; Horiuchi M; Kim-Mitsuyama S; Mori Y; Morishita R; Yamagishi S
Biochem Biophys Res Commun; 2011 Jan; 404(1):434-7. PubMed ID: 21130741
[TBL] [Abstract][Full Text] [Related]
12. Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques.
Noda A; Fushiki H; Murakami Y; Sasaki H; Miyoshi S; Kakuta H; Nishimura S
Nucl Med Biol; 2012 Nov; 39(8):1232-5. PubMed ID: 22890047
[TBL] [Abstract][Full Text] [Related]
13. Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.
Miura S; Okabe A; Matsuo Y; Karnik SS; Saku K
Hypertens Res; 2013 Feb; 36(2):134-9. PubMed ID: 23034464
[TBL] [Abstract][Full Text] [Related]
14. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
Patny A; Desai PV; Avery MA
Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
[TBL] [Abstract][Full Text] [Related]
15. Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.
Hamada T; Mizuta E; Kondo T; Hirai M; Yamada K; Kato M; Shigemasa C; Yamamoto Y; Ninomiya H; Igawa O; Hisatome I
Arzneimittelforschung; 2010; 60(2):71-5. PubMed ID: 20329654
[TBL] [Abstract][Full Text] [Related]
16. Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analyses.
Kakuta H; Kurosaki E; Niimi T; Gato K; Kawasaki Y; Suwa A; Honbou K; Yamaguchi T; Okumura H; Sanagi M; Tomura Y; Orita M; Yonemoto T; Masuzaki H
J Pharmacol Exp Ther; 2014 Apr; 349(1):10-20. PubMed ID: 24424487
[TBL] [Abstract][Full Text] [Related]
17. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
Takai S; Kirimura K; Jin D; Muramatsu M; Yoshikawa K; Mino Y; Miyazaki M
Hypertens Res; 2005 Jul; 28(7):593-600. PubMed ID: 16335888
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
Kishi T; Hirooka Y; Konno S; Sunagawa K
J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Janke J; Clasen R; Unger T; Kintscher U
Circulation; 2004 May; 109(17):2054-7. PubMed ID: 15117841
[TBL] [Abstract][Full Text] [Related]
20. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.
Miura M; Satoh S; Kagaya H; Saito M; Inoue T; Ohkubo T; Habuchi T; Suzuki T
J Clin Pharm Ther; 2009 Dec; 34(6):683-92. PubMed ID: 20175802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
